Skip to main content

Cancer Moonshot℠ – Funding Opportunities

The funding opportunity announcements (FOAs) listed below highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.

Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.

 

Open Funding Opportunity Announcements (FOAs)
BRP Recommendation Title Announcement Number Receipt Date
New Enabling Cancer Technologies Spatial Sequencing Technologies with Single Cell Resolution for Cancer Research PHS 2020-1/Topic 403 10/23/2019
New Enabling Cancer Technologies Subcellular Microscopy and -Omics in Cancer Cell Biology PHS 2020-1/Topic 404  10/23/2019
New Enabling Cancer Technologies Intra-Tumor Sensing Technologies for Tumor Pharmacotyping PHS 2020-1/Topic 405 10/23/2019
Prevention and Early Detection Software for Patient Navigation Through the Cancer Care Continuum PHS 2020-1/Topic 406 10/23/2019
National Cancer Data Ecosystem Cloud-Based Software for the Cancer Research Data Commons PHS 2020-1/Topic 407 10/23/2019
Generation of Human Tumor Atlases Tools and Technologies for Visualizing Multi-Scale Data PHS 2020-1/Topic 408 10/23/2019
Network for Patient Engagement Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement PHS 2020-1/Topic 410 10/23/2019
Symptom Management Research Software Enabling Data Integration from Wearable Sensors for Cancer Patients PHS 2020-1/Topic 412 10/23/2019
Direct Patient Engagement Network Patient Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) RFA-CA-19-045 10/30/2019
Direct Patient Engagement Network  Patient Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) RFA-CA-19-046 10/30/2019
Cancer Immunotherapy Translational Science Network Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) PAR-17-245 Multiple
Cancer Immunotherapy Translational Science Network Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) PAR-17-244 Multiple
Cancer Immunotherapy Translational Science Network Metabolic Reprogramming to Improve Immunotherapy (R21) PAR-16-229 Multiple
Cancer Immunotherapy Translational Science Network Metabolic Reprogramming to Improve Immunotherapy (R01) PAR-16-228 Multiple
Drivers of Childhood Cancers Gene Fusions in Pediatric Sarcomas (R21) PA-16-252 Multiple
Drivers of Childhood Cancers Gene Fusions in Pediatric Sarcomas (R01) PA-16-251 Multiple
Generation of Human Tumor Atlases Emerging Questions in Cancer Systems Biology (U01) PAR-16-131 Multiple
Therapeutic Target Identification to Overcome Resistance Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed) RFA-CA-19-049 Multiple
Symptom Management Research Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors  RFA-CA-19-033 01/03/2020
  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Moonshot℠ – Funding Opportunities was originally published by the National Cancer Institute.”